Zhu, Shuangli

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions

Yi, M., Zheng, X., Niu, M., Zhu, S., Ge, H., & Wu, K. (2022) · Molecular Cancer

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 1,445

Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers

Yi, M., Niu, M., Zhang, J., Li, S., Zhu, S., Yan, Y., Li, N., Zhou, P., Chu, Q., & Wu, K. (2021) · Journal of Hematology & Oncology

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 163

Focal adhesion kinase: from biological functions to therapeutic strategies

Tan, X., Yan, Y., Song, B., Zhu, S., Mei, Q., & Wu, K. (2023) · Experimental Hematology & Oncology

Cell Adhesion Molecules ResearchCellular Mechanics and Interactions

Cited by 158

Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China

Zhang, Y., Wang, D., Yan, D., Zhu, S., Liu, J., Wang, H., Zhao, S., Yu, D., Nan, L., An, J., et al. (2010) · Journal of Clinical Microbiology

Viral Infections and Immunology ResearchEvolution and Genetic Dynamics

Cited by 143

Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer

Zhang, H., Zhu, S., Zhou, H., Li, R., Xia, X., & Xiong, H. (2023) · Frontiers in Oncology

Ferroptosis and cancer prognosisBreast Cancer Treatment Studies

Cited by 46

Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019–2021

Yang, H., Qi, Q., Zhang, Y., Wen, N., Cao, L., Liu, Y., Fan, C., Yan, D., Zhu, X., Hao, L., et al. (2023) · JAMA Network Open

Viral Infections and Immunology ResearchVaccine Coverage and Hesitancy

Cited by 13